PODCAST: WAIT, HOW DO YOU SPELL THAT?

LATEST PATIENT WORTHY ARTICLES

Homozygous Familial Hypercholesterolemia

Praluent Now FDA-Approved for HoFH

  At the start of April 2021, the Food and Drug Administration (FDA) approved Regeneron Pharmaceutical’s Praluent (alirocumab), a treatment for patients aged 18+ with

Read More »

GET INVOLVED

STUDY OF THE WEEK

UPCOMING EVENTS

  1. Intercept Pharmaceuticals’ Living with PBC: Learning Together

    April 14
  2. Angel Aid Cares’ Rare Mother Meetup

    April 14 @ 6:00 pm - 7:00 pm
  3. The MDS Foundation’s Clinical Implications of Genetic Mutations in Myelodysplastic Syndromes Webinar

    April 17 @ 12:00 pm - 1:00 pm
  4. Cystic Fibrosis Research, Inc.’s Online Support Group for Adults with Cystic Fibrosis

    April 19 @ 6:00 pm - 7:30 pm
  5. Cystic Fibrosis Research, Inc.’s Online Support Group for Cystic Fibrosis Caregivers

    April 20 @ 5:00 pm - 6:00 pm

RARE CLASSROOM

Welcome to the Rare Classroom, a new series from Patient Worthy. Rare Classroom is designed for the curious reader who wants to get informed on some of the rarest, most mysterious diseases and conditions. This series is an opportunity to learn the basics about some of the diseases that almost no one hears much about.

FOLLOW US ON INSTAGRAM